Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients.
Granata V, Fusco R, Costa M, Picone C, Cozzi D, Moroni C, La Casella GV, Montanino A, Monti R, Mazzoni F, Grassi R, Malagnino VG, Cappabianca S, Grassi R, Miele V, Petrillo A. Granata V, et al. Among authors: montanino a. Cancers (Basel). 2021 Aug 7;13(16):3992. doi: 10.3390/cancers13163992. Cancers (Basel). 2021. PMID: 34439148 Free PMC article.
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer.
Cappuzzo F, Morabito A, Normanno N, Bidoli P, Del Conte A, Giannetta L, Montanino A, Mazzoni F, Buosi R, Burgio MA, Cerea G, Chiari R, Cortinovis D, Finocchiaro G, Foltran L, Migliorino MR, Tiseo M, Ferrari S, De Marinis F. Cappuzzo F, et al. Among authors: montanino a. Lung Cancer. 2016 Sep;99:31-7. doi: 10.1016/j.lungcan.2016.06.008. Epub 2016 Jun 14. Lung Cancer. 2016. PMID: 27565910 Clinical Trial.
The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients.
Rachiglio AM, Fenizia F, Piccirillo MC, Galetta D, Crinò L, Vincenzi B, Barletta E, Pinto C, Ferraù F, Lambiase M, Montanino A, Roma C, Ludovini V, Montagna ES, De Luca A, Rocco G, Botti G, Perrone F, Morabito A, Normanno N. Rachiglio AM, et al. Among authors: montanino a. Cancers (Basel). 2019 Mar 10;11(3):341. doi: 10.3390/cancers11030341. Cancers (Basel). 2019. PMID: 30857358 Free PMC article.
Pembrolizumab in lung cancer: current evidence and future perspectives.
Palumbo G, Carillio G, Manzo A, Montanino A, Sforza V, Costanzo R, Sandomenico C, Manna C, Luca G, Piccirillo MC, Daniele G, Cecio R, Botti G, Totaro G, Muto P, Picone C, Esposito G, Normanno N, Morabito A. Palumbo G, et al. Among authors: montanino a. Future Oncol. 2019 Oct;15(29):3327-3336. doi: 10.2217/fon-2019-0073. Epub 2019 Aug 21. Future Oncol. 2019. PMID: 31432705 Clinical Trial.
The safety of atezolizumab plus chemotherapy for the treatment of metastatic lung cancer.
Manzo A, Carillio G, Montanino A, Sforza V, Palumbo G, Esposito G, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Botti G, Totaro G, Muto P, Picone C, Normanno N, Morabito A. Manzo A, et al. Among authors: montanino a. Expert Opin Drug Saf. 2020 Jul;19(7):775-783. doi: 10.1080/14740338.2020.1767584. Epub 2020 May 26. Expert Opin Drug Saf. 2020. PMID: 32400223 Review.
Immunotherapy in Small Cell Lung Cancer.
Esposito G, Palumbo G, Carillio G, Manzo A, Montanino A, Sforza V, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Botti G, Totaro G, Muto P, Picone C, Normanno N, Morabito A. Esposito G, et al. Among authors: montanino a. Cancers (Basel). 2020 Sep 4;12(9):2522. doi: 10.3390/cancers12092522. Cancers (Basel). 2020. PMID: 32899891 Free PMC article. Review.
Quantitative imaging decision support (QIDSTM) tool consistency evaluation and radiomic analysis by means of 594 metrics in lung carcinoma on chest CT scan.
Fusco R, Granata V, Mazzei MA, Meglio ND, Roscio DD, Moroni C, Monti R, Cappabianca C, Picone C, Neri E, Coppola F, Montanino A, Grassi R, Petrillo A, Miele V. Fusco R, et al. Among authors: montanino a. Cancer Control. 2021 Jan-Dec;28:1073274820985786. doi: 10.1177/1073274820985786. Cancer Control. 2021. PMID: 33567876 Free PMC article.
RET Inhibitors in Non-Small-Cell Lung Cancer.
Cascetta P, Sforza V, Manzo A, Carillio G, Palumbo G, Esposito G, Montanino A, Costanzo R, Sandomenico C, De Cecio R, Piccirillo MC, La Manna C, Totaro G, Muto P, Picone C, Bianco R, Normanno N, Morabito A. Cascetta P, et al. Among authors: montanino a. Cancers (Basel). 2021 Sep 1;13(17):4415. doi: 10.3390/cancers13174415. Cancers (Basel). 2021. PMID: 34503226 Free PMC article. Review.
Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion.
Morabito A, Manzo A, Montanino A, Rachiglio AM, Sforza V, Pasquale R, Costanzo R, Maiello MR, Sandomenico C, Gallo M, Palumbo G, De Luca A, La Rocca A, Martucci N, De Cecio R, Picone C, Lastoria S, Normanno N. Morabito A, et al. Among authors: montanino a. Oncologist. 2022 Feb 3;27(1):7-12. doi: 10.1093/oncolo/oyab002. Oncologist. 2022. PMID: 35305107 Free PMC article.
Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer.
Palumbo G, Esposito G, Carillio G, Manzo A, Montanino A, Sforza V, Costanzo R, Sandomenico C, La Manna C, Martucci N, La Rocca A, De Luca G, Piccirillo MC, De Cecio R, Perrone F, Totaro G, Muto P, Picone C, Normanno N, Morabito A. Palumbo G, et al. Among authors: montanino a. Explor Target Antitumor Ther. 2020;1(2):117-130. doi: 10.37349/etat.2020.00008. Epub 2020 Apr 28. Explor Target Antitumor Ther. 2020. PMID: 36046069 Free PMC article. Review.
53 results